| 5602 |
Centers for Disease Control and Prevention |
Html |
en |
Hydrazine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6488 |
Centers for Disease Control and Prevention |
Html |
en |
Promoting active communities in a culture of distracted driving |
Efforts to improve health outcomes through behavioral modification are often complicated by external factors that may thwart success and introduce potential harm. Factors associated with traffic safety present a contemporary challenge to efforts to promote physical activity. One example is the difficulty of encouraging pedestrian-based physical activity because of the growing prevalence of distracted driving. |
| pedestrian-based physical activity | 0.60409 |
| communications technology sector | 0.514475 |
| active communities | 0.531982 |
| Texas A&M University | 0.53029 |
| environmental modifications | 0.528527 |
| monthly text messages | 0.529517 |
| Matthew Lee Smith | 0.512769 |
| Rural Public Health | 0.639553 |
| reduced collision claims | 0.522761 |
| commercial automotive industry | 0.519177 |
| portable technology device | 0.527996 |
| College Station | 0.560722 |
| Mark E. Benden | 0.521829 |
| Science Center School | 0.617911 |
| health outcomes | 0.515245 |
| bicycle lanes | 0.550293 |
| Traffic Safety Association | 0.552938 |
| active transportation | 0.551606 |
| roadway design accounts | 0.546953 |
| Healthy People | 0.525273 |
| markedly increased injuries | 0.520261 |
| public health | 0.732922 |
| street-scale environmental policies | 0.543782 |
| distracted driving | 0.628849 |
|
| overall roadway safety | 0.554407 |
| bicyclists | 0.547642 |
| mobile communication technology | 0.532008 |
| automobile-pedestrian interactions | 0.530585 |
| pedestrians | 0.620233 |
| street design features | 0.537398 |
| A&M Health Science | 0.63285 |
| road users | 0.545912 |
| Texas A&M Health | 0.632675 |
| traffic safety | 0.617277 |
| physical activity | 0.995746 |
| promotes physical activity | 0.58713 |
| public health movement | 0.573079 |
| Complete Streets initiative | 0.655312 |
| proper technological solutions | 0.512361 |
| Health Science Center | 0.63436 |
| hand-held cellular telephone | 0.533732 |
| Public Health Service | 0.566616 |
| physical activity opportunities | 0.586768 |
| unsafe street environments | 0.532751 |
| independently rising growth | 0.518548 |
| specifies active transportation | 0.547873 |
| modifiable public infrastructures | 0.56629 |
|
CLICK HERE |
| 7744 |
Centers for Disease Control and Prevention |
Html |
en |
Bartonella |
Bartonella bacteria cause several diseases in humans. The three most common are cat scratch disease, caused by B. henselae; trench fever, caused by B. quintana; and Carrión's disease, caused by B. bacilliformis.
|
| Carrión’s disease | 0.762886 |
| B. quintana | 0.703318 |
| B. bacilliformis | 0.564359 |
| diseases | 0.351633 |
|
| Bartonella bacteria | 0.955946 |
| cat scratch disease | 0.966092 |
| trench fever | 0.80794 |
| humans | 0.424392 |
|
CLICK HERE |
| 9944 |
Centers for Disease Control and Prevention |
Html |
en |
Tribes and Indian Organizations - Tribal Support |
CDC/ATSDR Tribal Support is the primary link between CDC, the Agency for Toxic Substance and Disease Registry (ATSDR), and tribal governments. CDC/ATSDR’s tribal support activities focus on fulfilling CDC's supportive role in ensuring that American Indian/Alaska Native (AI/AN) communities receive public health services that keep them safe and healthy. |
| CDC/Indian Health Service | 0.59623 |
| critical element | 0.444604 |
| federally recognized tribes | 0.825638 |
| disease conditions | 0.452409 |
| Interior | 0.351312 |
| public health authorities | 0.587702 |
| health services research | 0.598728 |
| CDC/ATSDR Tribal Consultation | 0.584389 |
| health disparities | 0.468804 |
| core component | 0.43998 |
| disease control | 0.451311 |
| Federally Recognized Indian | 0.85133 |
| tribal lands | 0.474414 |
| rural Indian organizations. | 0.607236 |
| federally recognized tribe | 0.825485 |
| epidemiological analysis | 0.471086 |
| recent Notice | 0.459151 |
| surveillance data | 0.452134 |
| prevention programs | 0.446512 |
| Native-serving organizations | 0.461319 |
| Native American Research | 0.590557 |
| faculty development | 0.442633 |
| AI/AN communities | 0.541393 |
| American Indians | 0.451459 |
|
| official listing | 0.471763 |
| lists contact information | 0.582042 |
| United States | 0.451176 |
| Secretary | 0.363113 |
| indian tribes | 0.691238 |
| disease outbreaks | 0.455017 |
| AI/AN tribes | 0.54004 |
| Federal Register | 0.619017 |
| NARCH | 0.38393 |
| research training | 0.456722 |
| Tribal Epidemiology Centers | 0.601937 |
| epidemiological studies | 0.470149 |
| Tribal Leaders Directory | 0.609498 |
| Tribal List Act | 0.650783 |
| Alaska Natives | 0.457336 |
| developmental process | 0.43629 |
| Pamunkey Indian Tribe | 0.997837 |
| tribally based organizations | 0.621119 |
| research infrastructure | 0.448511 |
| urban Indian organizations | 0.627117 |
| Alaska Native tribe | 0.665228 |
| American Indian/Alaska Native | 0.603916 |
| national organizations | 0.455086 |
| tribal organizations | 0.484141 |
|
CLICK HERE |
| 11015 |
Centers for Disease Control and Prevention |
Html |
en |
Meningococcal - Community Settings Risk Factors | CDC |
College freshmen, especially those who live in dormitories, are at a slightly increased risk for bacterial meningitis caused by Neisseria meningitidis bacteria (meningococcal disease) compared with other persons of the same age. |
| college campuses | 0.520545 |
| CDC | 0.361834 |
| meningococcal disease outbreak | 0.699232 |
| teens | 0.325526 |
| states | 0.350127 |
| residence halls | 0.434973 |
| college students | 0.593919 |
| vaccination waiver | 0.459229 |
| meningococcal conjugate vaccines | 0.853431 |
| meningococcal vaccine recommendations | 0.723035 |
| incoming students | 0.536436 |
| colleges | 0.357148 |
| large groups | 0.445096 |
| 16th birthday | 0.428756 |
|
| people | 0.350583 |
| maximum protection | 0.422021 |
| meningococcal disease | 0.9863 |
| certain students | 0.425594 |
| non-first-year college students | 0.508996 |
| Infectious diseases | 0.446853 |
| serogroup | 0.478635 |
| Recent data | 0.443432 |
| booster dose | 0.432847 |
| young adults | 0.442002 |
| school enrollment | 0.425756 |
| first-year college students | 0.530126 |
| risk | 0.372249 |
|
CLICK HERE |
| 11768 |
Centers for Disease Control and Prevention |
Html |
en |
Autism Spectrum Disorder (ASD) - Screening and Diagnosis |
Autism Spectrum Disorders (ASDs) are a group of developmental disabilities that can cause significant social, communication and behavioral challenges. CDC is working to find out how many children have ASDs, discover the risk factors, and raise awareness of the signs. |
| final diagnosis | 0.263272 |
| developmental screening test | 0.592039 |
| developmental screening | 0.748382 |
| family member | 0.236567 |
| developmental problems | 0.558539 |
| experienced professional | 0.271883 |
| ASD | 0.904698 |
| basic skills | 0.265396 |
| children | 0.368225 |
| Additional screening | 0.528238 |
| well-child doctor visits | 0.869253 |
| autism spectrum disorder | 0.518818 |
| neurological testing | 0.218582 |
| thorough review | 0.233317 |
| higher risk | 0.227138 |
|
| developmental delays | 0.594324 |
| regular well-child doctor | 0.863691 |
| comprehensive diagnostic evaluation | 0.404084 |
| blood test | 0.281057 |
| short test | 0.255964 |
| diagnostic tools | 0.23036 |
| primary care doctor | 0.414939 |
| medical test | 0.27071 |
| comprehensive evaluation | 0.219362 |
| vision screening | 0.295228 |
| genetic testing | 0.222203 |
| high risk | 0.472205 |
| medical testing | 0.213329 |
| low birth weight | 0.848976 |
|
CLICK HERE |
| 13042 |
Centers for Disease Control and Prevention |
Html |
en |
Employment and Activity Limitations Among Adults with Chronic Obstructive Pulmonary Disease - United States, 2013 |
Anne G. Wheaton, PhD1, Timothy J. Cunningham, PhD1, Earl S. |
| COPD patients | 0.761916 |
| Opinion Research Response | 0.47204 |
| limitation measures | 0.521085 |
| health care provider | 0.478594 |
| Janet B. Croft | 0.474034 |
| various activity limitations | 0.52461 |
| current smokers | 0.58667 |
| smoking status | 0.501995 |
| state health departments | 0.482105 |
| health care providers | 0.526524 |
| current smoking | 0.507534 |
| progressive respiratory conditions | 0.476515 |
| response rate | 0.490345 |
| activity limitation characteristics | 0.511354 |
| noninstitutionalized civilian adults | 0.486069 |
| special equipment | 0.559794 |
| health problems | 0.526243 |
| physician-diagnosed COPD | 0.725489 |
| smoking cessation | 0.487584 |
| pulmonary rehabilitation program | 0.476408 |
| chronic bronchitis | 0.476256 |
| Earl S. Ford | 0.472972 |
| Behavioral Risk Factor | 0.471639 |
| physical activity status | 0.536079 |
| obstructive pulmonary disease | 0.482224 |
|
| United States | 0.611391 |
| adults | 0.56228 |
| Timothy J. Cunningham | 0.473581 |
| respiratory symptoms | 0.468311 |
| Anne G. Wheaton | 0.534585 |
| activity limitations | 0.829415 |
| Data Quality Report | 0.476081 |
| greater educational level | 0.468047 |
| random-digit–dialed telephone survey | 0.470969 |
| activity limitation | 0.573155 |
| COPD prevalence | 0.74081 |
| important contributor | 0.477083 |
| U.S. adults | 0.54653 |
| age-adjusted prevalence | 0.503906 |
| response rates | 0.472357 |
| health | 0.531899 |
| physical activity | 0.666019 |
| median survey response | 0.474341 |
| current smoking status | 0.488865 |
| COPD diagnosis | 0.639241 |
| public health efforts | 0.469257 |
| American Indian/Alaska Native | 0.467485 |
| pulmonary rehabilitation | 0.565368 |
| COPD status | 0.674639 |
|
CLICK HERE |
| 14317 |
Centers for Disease Control and Prevention |
Image |
null |
How Potassium Iodide (KI) Works| Infographic |
null |
|
|
CLICK HERE |
| 15933 |
Centers for Disease Control and Prevention |
Html |
en |
Sanofi Pasteur Reports Flu Vaccine Recall for Three Lots of Vaccine from 2014-2015 Season |
Sanofi Pasteur Reports Flu Vaccine Recall for Three Lots of Vaccine from 2014-2015 Season - CDC |
| pre-specified potency limit | 0.410405 |
| potency standards | 0.352642 |
| virus components | 0.342239 |
| potency | 0.50771 |
| prevention options | 0.26957 |
| FDA | 0.251949 |
| CDC | 0.280074 |
| United States | 0.391469 |
| active ingredient | 0.273011 |
| suboptimal protection | 0.27232 |
| questions | 0.227593 |
| flu vaccine | 0.88042 |
| multidose vials | 0.542074 |
| optimal effectiveness | 0.276419 |
| Fluzone® Quadrivalent vaccine | 0.729623 |
| flu activity | 0.412475 |
| Hemisphere flu vaccine | 0.55367 |
| Yamagata virus components | 0.335481 |
| Fluzone® vaccines | 0.290295 |
| Sanofi Pasteur Customer | 0.392017 |
| quadrivalent flu vaccine | 0.817072 |
| flu vaccines | 0.363072 |
| flu treatment | 0.338062 |
|
| Victoria lineage | 0.345461 |
| pre-specified limits | 0.269161 |
| recall | 0.255106 |
| extended period | 0.266522 |
| Yamagata lineage | 0.278709 |
| revaccination | 0.229371 |
| multi-dose vials | 0.30402 |
| Southern Hemisphere | 0.543097 |
| Additional information | 0.270885 |
| Sanofi Pasteur | 0.739216 |
| Influenza Viruses | 0.315322 |
| safety concern | 0.276213 |
| pre-specified limit | 0.273457 |
| people | 0.326571 |
| doctor | 0.227606 |
| vaccine | 0.973714 |
| unused doses | 0.271977 |
| new flu vaccine | 0.531223 |
| Southern Hemisphere vaccines | 0.349838 |
| flu season | 0.338422 |
| expiration | 0.21719 |
| Fluzone® Quadrivalent flu | 0.530218 |
| time | 0.245621 |
|
CLICK HERE |
| 16156 |
Centers for Disease Control and Prevention |
Html |
es |
Todos pueden ayudar a detener el hostigamiento de los niños que tienen el síndrome de Gilles de la Tourette - Especiales CDC - CDC en Español |
Del 15 de mayo al 15 de junio es el Mes de Concientización sobre el Síndrome de Tourette. El tema de este año es un desafío para aumentar la concientización y la aceptación del síndrome de Gilles de la Tourette (#DesafíoST). Conozca la información sobre los tics y el síndrome de Gilles de la Tourette (también llamado síndrome de Tourette o TS, por sus siglas en inglés) y sepa cómo puede aumentar la aceptación al ayudar a detener el hostigamiento de los niños con este síndrome. |
| Archivo Apple Quicktime | 0.831324 |
| malas palabras | 0.773977 |
| Archivo Zip Comprimido | 0.827813 |
| Archivo Microsoft PowerPoint | 0.844402 |
| Archivo Adobe PDF | 0.828397 |
| Archivo Microsoft Excel | 0.823898 |
|
| pequeña cantidad | 0.771885 |
| boy scouts | 0.742085 |
| Archivo Microsoft | 0.982742 |
| Embajadores Juveniles | 0.752186 |
| Archivo Microsoft Word | 0.842044 |
|
CLICK HERE |